Active, not recruitingPhase 4NCT06752850

A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis

Studying Hemophilia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Swedish Orphan Biovitrum
Principal Investigator
Study Physician
Sobi AB
Intervention
Efanesoctocog alfa(drug)
Enrollment
37 enrolled
Eligibility
12 years · All sexes
Timeline
2024 – 2026

Study locations (10)

Collaborators

PSI CRO

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06752850 on ClinicalTrials.gov

Other trials for Hemophilia

Additional recruiting or active studies for the same condition.

See all trials for Hemophilia →

← Back to all trials